J. Lipid Res. Did you know there is a large type edition? Click here.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


A more recent version of this article appeared on December 1, 2005

Papers In Press, published online ahead of print September 18, 2005
J. Lipid Res., doi:10.1194/jlr.M500313-JLR200
This Article
Right arrow Full Text (Accepted Manuscript)
Right arrow All Versions of this Article:
M500313-JLR200v1
46/12/2706    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wijesinghe, D. S.
Right arrow Articles by Chalfant, C. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wijesinghe, D. S.
Right arrow Articles by Chalfant, C. E.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Submitted on July 21, 2005
Revised on September 12, 2005
Accepted on September 18, 2005

Substrate specificity of human ceramide kinase

Dayanjan S. Wijesinghe, Autumn Massiello, Preeti Subramanian, Zdzislaw Szulc, Alicja Bielawska, and Charles E. Chalfant

Department of Biochemistry, Virginia Commonwealth University, Richmond, VA 23298-0614

Corresponding Author: cechalfant{at}vcu.edu

Previous studies by our laboratory have established ceramide kinase (CERK) as a critical mediator of eicosanoid synthesis. To date, CERK has not been well characterized in vitro. In this study, we investigated the substrate specificity of CERK using baculovirus-expressed hCERK (6XHis) and a newly designed assay based on mixed-micelles of Triton X-100. Results indicate that the ability of CERK to recognize ceramide as a substrate is stereospecific as CERK only phosphorylated D-e-C16:0 ceramide and not the ceramide stereoisomers, L-e-C16:0 ceramides, D-t-C16:0 ceramides, and L-t-C16:0 ceramides. A minimum of a 12 carbon acyl chain was required for normal CERK activity as shortening of the acyl chain below 12 carbons dramatically reduced the substrate specificity. The 4-5 trans double bond was important for substrate recognition as D-e-4,5-Cis, D-e-dihydro, D-e-dehydro, and D-e-phyto ceramides demonstrated a marked decrease in CERK activity when compared to natural ceramide. These results did not show any significant discrimination by CERK between ceramides with long saturated and long unsaturated fatty acyl chains as substrates. Methylation of the primary hydroxyl group resulted in a loss of activity confirming that CERK produces C1P versus C3P. In addition, methylation of the secondary hydroxyl group drastically decreased the phosphorylation of the substrate by the enzyme suggesting the 3´ OH group is required for substrate recognition. These results also indicated that the free hydrogen of the secondary amide group to be critical for substrate recognition as N-methyl ceramides failed to become phosphorylated by CERK. Lastly, the sphingoid chain was also required for substrate recognition by CERK. Together, these results indicate a very high specificity for substrate recognition by CERK explaining the use of ceramide and not sphingosine nor diacylglycerol as substrates.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Biophys. JHome page
E. E. Kooijman, J. Sot, L.-R. Montes, A. Alonso, A. Gericke, B. de Kruijff, S. Kumar, and F. M. Goni
Membrane Organization and Ionization Behavior of the Minor but Crucial Lipid Ceramide-1-Phosphate
Biophys. J., June 1, 2008; 94(11): 4320 - 4330.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
L. G. Wooten-Blanks, P. Song, C. E. Senkal, and B. Ogretmen
Mechanisms of ceramide-mediated repression of the human telomerase reverse transcriptase promoter via deacetylation of Sp3 by histone deacetylase 1
FASEB J, October 1, 2007; 21(12): 3386 - 3397.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
N. F. Lamour, R. V. Stahelin, D. S. Wijesinghe, M. Maceyka, E. Wang, J. C. Allegood, A. H. Merrill Jr., W. Cho, and C. E. Chalfant
Ceramide kinase uses ceramide provided by ceramide transport protein: localization to organelles of eicosanoid synthesis
J. Lipid Res., June 1, 2007; 48(6): 1293 - 1304.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Bandyopadhyay, R. Zhan, Y. Wang, S. K. Pai, S. Hirota, S. Hosobe, Y. Takano, K. Saito, E. Furuta, M. Iiizumi, et al.
Mechanism of Apoptosis Induced by the Inhibition of Fatty Acid Synthase in Breast Cancer Cells
Cancer Res., June 1, 2006; 66(11): 5934 - 5940.
[Abstract] [Full Text] [PDF]


Home page
Mol. Interv.Home page
N. F. Lamour and C. E. Chalfant
Ceramide-1-phosphate: The "missing" link in eicosanoid biosynthesis and inflammation
Mol. Interv., December 1, 2005; 5(6): 358 - 367.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 All ASBMB Journals   Journal of Biological Chemistry 
 Molecular and Cellular Proteomics   ASBMB Today 
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.